John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 12,478 shares at $55.86 ($697K) on 2021-01-05, disclosed to the SEC on 2021-01-05.
Open-market sale of $697k NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.86 | 6,239 | $349K | 50.0% |
| 2 | $55.86 | 6,239 | $349K | 50.0% |
| Total | $55.86 avg | 12,478 | $697K | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |